Your session is about to expire
← Back to Search
Probiotic
Goodbelly for Peripheral Vascular Disease
N/A
Waitlist Available
Research Sponsored by Medical College of Wisconsin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to 24 hours after consumption and approximately 7 days after consumption
Awards & highlights
Summary
This trial is testing whether a drug that improves FMD can also reduce the risk of cardiovascular disease.
Eligible Conditions
- Peripheral Vascular Disease
- High Cholesterol
- Cerebral Artery Disease
- High Blood Pressure
- Coronary Artery Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from baseline to 24 hours after consumption and approximately 7 days after consumption
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to 24 hours after consumption and approximately 7 days after consumption
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
change in baseline flow mediated dilation (FMD) after probiotic consumption
Secondary outcome measures
Interleukin-12
Interleukin-6
Interleukin-8
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: GoodBelly ProbioticExperimental Treatment1 Intervention
Subjects randomized to this arm consume one serving of the Goodbelly lactobacillus plantarum 299v probiotic
Group II: PlaceboPlacebo Group1 Intervention
Subjects randomized to this arm consume one serving of the Goodbelly that does not contain lactobacillus plantarum 299v
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Goodbelly
2020
N/A
~30
Find a Location
Who is running the clinical trial?
Medical College of WisconsinLead Sponsor
614 Previous Clinical Trials
1,162,853 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger